Severe Asthma ToolkitSevere Asthma Toolkit
HomeAboutSpecific PopulationsRegistriesContributorsContact
Twitter
  • What is Severe Asthma?
    • Overview
    • Definition
    • Prevalence & Burden
    • Pathophysiology
    • Symptoms
    • Severe Asthma Attacks / Exacerbations / Flare-ups
    • Asthma Phenotypes
  • Diagnosis & Assessment
    • Overview
    • Diagnosis Overview
    • Assessment Overview
    • Lung Function Assessments
    • Questionnaires
    • Allergy Assessments
    • Phenotyping
    • Bronchoscopy
    • Imaging
    • Occupational Asthma
  • Management
    • Overview
    • Asthma Education
      • About Severe Asthma
      • Asthma Pathophysiology
      • Medications Education
      • Self-Monitoring
      • Triggers
      • Review
    • Written Action Plans
    • Adherence
    • Inhaler Technique
    • Physical Activity & Exercise
    • Interdisciplinary Approach & Multidimensional Assessment
    • Referral
  • Medications
    • Overview
    • Relievers
    • Preventers / Controllers
    • Add-on Therapies
    • Monoclonal Antibodies
    • Bronchial Thermoplasty
  • Co-Morbidities
    • Overview
    • Pulmonary & Upper Airways
      • Allergic & Non-Allergic Rhinitis
      • Chronic Rhinosinusitis
      • Dysfunctional Breathing
      • Vocal Cord Dysfunction
      • Chronic Obstructive Pulmonary Disease
      • Bronchiectasis
      • Obstructive Sleep Apnoea
    • Extra-Pulmonary
      • Obesity
      • Anxiety & Depression
      • Gastro-oesophageal Reflux Disease (GORD)
      • Osteoporosis
      • Cardiovascular Disease & Metabolic Disease
  • Living with Severe Asthma
    • Overview
    • Daily Symptom Burden
    • Mental & Emotional Health
    • Intimacy & Relationships
    • Self-Management Support
    • Medication Use & Costs
    • Experience of Care
    • Experience of Asthma Attacks
    • Prognosis
  • Establishing a Clinic
    • Overview
    • Set-up
    • Staffing & Multidisciplinary Team Approach
    • Facilities
    • Delivery Approach
    • Tailored Referrals
    • Evaluation
    • Opportunities for Training & Research
    • Barriers & Hurdles
  • Paediatrics
    • Overview
    • Management in Paediatrics
    • Assessment in Paediatrics
    • Alternative Diagnosis & Co-Morbidities in Paediatrics
    • Psychosocial Issues in Paediatrics
    • Medications in Paediatrics
    • Asthma in the Adolescent Population
  • Resources
    • Overview
    • Clinic Recommendations
    • Infographics
    • Asthma Assessment Resources
    • Systematic & Multidimensional Assessment Resources
      • Airway Components
      • Comorbidity Components
      • Risk Factor Components
    • Translation & Implementation
    • Case Studies
    • Presentations
    • Videos
    • Relevant Links
    • Key References

Psychosocial Issues in Paediatrics

Home Paediatrics & Adolescents Psychosocial Issues in Paediatrics
a young girl with Psychosocial Issues in Paediatrics with Severe Asthma

The following content is developed for children with severe asthma. Consider in conjunction with the adult Anxiety & Depression section

Psychosocial Issues in Paediatrics with Severe Asthma

Psychosocial issues can interplay with several aspects of severe asthma:

  • Anxiety and depression are more common in children with asthma than in children who do not have asthma (Dudeney et al. 2017)
  • Anxiety and depression in children with asthma is associated with poorer asthma control (Lehrer et al. 2002)
  • Psychosocial issues within the family are associated with poorer asthma outcomes in children (Kaugars et al. 2004), and are a significant risk factor for childhood deaths from asthma (Fitzgerald et al. 2015)
  • Some asthma treatments including corticosteroids and montelukast are associated with sleep disturbance, anxiety and depression (Aldea Perona et al. 2016)
It is important to screen for and appropriately manage or refer children with anxiety and depression.

Anxiety

Anxiety has a complex relationship with asthma. It may act as a trigger for an asthma exacerbation, mimic symptoms of an asthma exacerbation or worsen an exacerbation. Children and adolescents with asthma are three times more likely to suffer from an anxiety disorder than those who do not have asthma and when present, anxiety is associated with an increase in asthma symptoms.

Depression

Depression is associated with higher morbidity and mortality in children with asthma. It may also contribute to poor self-management including reduced medication compliance, poor symptom awareness and a reduced ability to identify worsening symptoms. On the other hand, an improvement in depressive symptoms can lead to an improvement in asthma control. The role of asthma medications in depression should also be considered.

Screening Tools for Anxiety and Depression

It is imperative that children are screened for anxiety or depression as part of their routine assessment. Possible screening tools are:

  • The Children’s Depression Inventory – Short Form (CDI-S; (Kovacs, 1992, Children’s Depression Inventory Manual)) for depressive symptoms. Information available here
  • The Spence Child Anxiety Scale – Parent or Child report (SCAS-P; (Nauta et al. 2004) and SCAS-C; (Spence 1998)) for anxiety symptoms. Information available here
  • Strength and Difficulties Questionnaires for emotional and behavioural assessment. Information available here

Possible Treatment Options

Treatments that target children’s knowledge, beliefs and behaviours are likely to improve compliance, management and long-term prognosis for children with asthma and psychological comorbidity. Cognitive behavioural therapy (CBT), which may involve education, relaxation training, targeting unhelpful thinking styles, exposure to fears and increasing approach behaviours is an efficacious treatment for children with asthma and anxiety (Papneja et al. 2006, Marriage et al. 2012, Sicouri et al. 2017), however further research is needed.

Psychosocial impact of asthma

Severe asthma can have a range of psychosocial effects on children, including:

  • School absence
  • Avoidance of sporting activities
  • Missing school camps
  • Reduced parental attention for siblings
  • Parental stress and psychological symptoms
  • Bullying
  • Post-traumatic stress disorder following a life-threatening exacerbation
  • Increased risk-taking behaviours (e.g. inhaler misuse associated with cigarettes, alcohol, marijuana or other drugs)

Previous
Next

Last Updated on February 13, 2019

Generic selectors
Exact matches only
Search in title
Search in content
Search in posts
Search in pages
Filter by Categories

More results...

  • Overview
  • Management in Paediatrics
  • Assessment in Paediatrics
  • Alternative Diagnosis & Co-Morbidities in Paediatrics
  • Psychosocial Issues in Paediatrics
  • Medications in Paediatrics
  • Asthma in the Adolescent Population
Consider this information in conjunction with the relevant sections:
Diagnosis & Assessment
Management
Medications
Co-Morbidities

We want to know who accesses the Severe Asthma Toolkit and how it is used. Please complete our survey.

Responses will inform the continued development of the Severe Asthma Toolkit and future translation and implementation activities. Any feedback you provide will be greatly appreciated.

Complete Survey

  • Website Terms of Use
  • Website Survey
© Copyright 2018    CRICOS Provider Number 00109J    The University of Newcastle, Australia